Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
about
Carvedilol versus non-selective beta-blockers for portal hypertension in cirrhosisBeta-blockers in liver cirrhosisSystematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosisClinical updates on carvedilol: a first choice beta-blocker in the treatment of cardiovascular diseasesThe effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis.Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis.Carvedilol in the treatment of portal hypertension.Management of varices in patients with cirrhosis.Beta-blockers in portal hypertension: new developments and controversies.Recent advances in cirrhotic cardiomyopathy.Is it time to replace propranolol with carvedilol for portal hypertension?A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis.Modulation of hepatic perfusion did not improve recovery from hepatic outflow obstruction.Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study.Carvedilol for portal hypertension in patients with cirrhosis.Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed.Antifibrotic Effects of Carvedilol and Impact of Liver Fibrosis on Carvedilol Pharmacokinetics in a Rat model.Severe carvedilol toxicity without overdose - caution in cirrhosis.Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.
P2860
Q24186341-107FA0F2-956F-4821-BF0D-8EE7C2F49A28Q27012922-B1E2E831-E142-48A2-9310-60FC37EA5DAFQ27013775-8DBC5E54-7A27-4B2A-9020-457E2446FB0EQ28270431-5A248EE0-759E-4E0B-8D53-EAB1FD2AAD9DQ35707623-749B8215-51E0-4993-9849-20E621E068E4Q36008972-55ED4D6D-FB98-46A1-BD05-0C2F65760E60Q37849484-D35D3DB3-31EB-459C-890E-38BD8E318083Q38094881-925CFBFE-6C6B-4D78-A9F8-74F77EB7DF74Q38153416-1ADBBEA8-E536-4FFC-B3E8-DB2C7E25BDB1Q38268965-EE2DA8E6-A418-46A5-9225-10B26FCF1480Q38493078-F1AAA0FB-C171-4829-BBBF-18AEB9D567DBQ39440287-89D00827-17D7-45B2-AE37-E2B65FD4EBD5Q41036385-3120E74B-3C1B-4FD2-85CD-9599402F491DQ41341900-92DD9ED4-76E0-4498-8874-29E96EDF4161Q43050079-65594075-3CA4-4C22-B5E1-9229D4307DEAQ45927000-C5F91DCB-613C-4973-9AF9-DB5E0A92C7F5Q46544701-36C56CE1-08C2-4100-B90D-4A6B084FBEDDQ47100753-494395E6-5115-443A-AF63-87BAB58F64E8Q47320079-FB5E5A7A-BC09-4692-9DF3-41D8F38D3A1C
P2860
Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Acute administration of carved ...... patients with viral cirrhosis.
@en
Acute administration of carved ...... patients with viral cirrhosis.
@nl
type
label
Acute administration of carved ...... patients with viral cirrhosis.
@en
Acute administration of carved ...... patients with viral cirrhosis.
@nl
prefLabel
Acute administration of carved ...... patients with viral cirrhosis.
@en
Acute administration of carved ...... patients with viral cirrhosis.
@nl
P2093
P2860
P1476
Acute administration of carved ...... patients with viral cirrhosis.
@en
P2093
Fa-Yauh Lee
Han-Chieh Lin
Ming-Chih Hou
Shou-Dong Lee
Yi-Tsau Huang
Ying-Ying Yang
P2860
P304
P356
10.1111/J.1572-0241.2004.40179.X
P407
P577
2004-10-01T00:00:00Z